PEAKS User Meeting & ASMS 2017

Join us for a complimentary lunch to celebrate the 65th ASMS Conference at our annual PEAKS User Meeting on Sunday, June 4th. This year, our guest speakers will present their exciting work using PEAKS software. To conclude the meeting, the PEAKS team will be presenting what’s to come for the future of PEAKS products, including:

  1. PTM quantification combined with protein quantification
  2. Accurate quantification by handling missing values
  3. Characterization of therapeutic proteins with disulfide bond mapping and glycan profiling

Guest Speakers

“Shedding light on the dark proteome: Roles of glycosylation in human diseases”

Dr. Joseph Zaia, Ph.D
Associate Director, Center for Biomedical Mass Spectrometry
Boston University School of Medicine

“Bioprospecting the Komodo dragon peptidome for new antimicrobials”

Dr. Barney Bishop, Ph.D
Associate Professor, Department of Chemistry & Biochemistry
George Mason University
*photo courtesy of GMU

“Systems biology of MHC class I antigen”

Dr. Stefan Tenzer, Ph.D
W2-Professor for Quantitative Proteomics & Head of Mass Spectrometry Core Facility
Johannes Gutenberg-University of Mainz

Collaborative Posters

  • MP 306 – Top-down Neuropeptide MALDI Imaging MS on FFPE Sections with High Mass Resolution and MS/MS Capabilities: Towards True “Mass Spectrometry Histochemistry”; Peter D. Verhaert1; Shane R. Ellis2; Martin R. L. Paine2; Dan Maloney3; Ron MA Heeren2; 1 Delft University of Technology, DELFT, Europe; 2 Maastricht Multi-Modal Molecular Imaging (M4I) Institute, Maastricht University, Maastricht, Netherlands; 3 Bioinformatics Solutions Inc, Waterloo, ON, Canada
  • ThP 599 – A General Optimized Protocol for Sequence and Glycoforms Characterization of Monoclonal Antibodies; Modupeola A Sowole1; Lin He2; Baozhen Shan2; Gilles A. Lajoie3; 1 University of Western Ontario, London, ON, Canada; 2 Bioinformatics Solutions Inc, Waterloo, ON, Canada; 3 University of Western Ontario, London , ON, Canada
  • ThP 655 – De Novo Sequencing Of Multiple Myeloma Immunoglobulin Heavy Chain CDR3 Clone From A Polyclonal Background; David H. Tse1, 2; Benson M. Linda1, 3; Benjamin J. Madden1, 3; Renee C. Tschumper1,4; Diane F. Jelinek1, 4; Angela Dispenzieri1, 5; K. Ilker Sen6; Baozhen Shan7; H. Robert Bergen, III1, 2, 3; 1 Mayo Clinic, Rochester, MN; 2 Dept. of Biochemistry and Molecular Biology, Rochester, MN; 3 Mayo Proteomics Research Core, Rochester, MN; 4 Dept. of Immunology, Rochester, MN; 5 Dept. of Hematology, Rochester, MN; 6 Protein Metrics Inc., San Carlos, CA; 7 Bioinformatics Solutions Inc, Waterloo, ON, Canada


BSI Posters